Paul Jude Tonna, Director at BioRestorative Therapies, Inc. (BRTX), bought 17,850 shares at $0.28 ($5K) on 2019-08-29, disclosed to the SEC on 2019-09-03.
Open-market purchase of $5k BRTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |